Natus Medical, Inc. (BABY) Tops Q2 EPS by 2c
Get Alerts BABY Hot Sheet
Join SI Premium – FREE
Natus Medical, Inc. (NASDAQ: BABY) reported Q2 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $86.3 million versus the consensus estimate of $84.85 million.
Natus Medical, Inc. sees Q3 2014 EPS of $0.28-$0.32, versus the consensus of $0.31. Natus Medical, Inc. sees Q3 2014 revenue of $86-89 million, versus the consensus of $87.14 million.
For earnings history and earnings-related data on Natus Medical, Inc. (BABY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- Carnival Corp. (CCL) tops Q1 expectations as booking volumes 'hit an all-time high'
- Koil Energy Solutions, Inc. (KLNG) Reports Q4 Loss of $0.07
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!